Key Takeaways
- Boosters are usually discussed by concern, not by skin-type label
- Hydration and dullness concerns are commonly matched with hyaluronic-acid boosters
- Firmness concerns are commonly matched with slow-building collagen biostimulators
- Skin type is a starting point, not a diagnosis — your clinician makes the actual match
"Which skin booster is right for me?" is a reasonable question with an unsatisfying answer: it depends. Boosters are not one thing, and the useful sorting tends to be less about whether you are "dry" or "oily" and more about what you would actually change if you could — more glow, less roughness, a firmer edge.
Still, skin type is where most people start, so it is a fair place to begin — as long as you treat it as a first lens rather than the final word.
A quick matching guide
| Skin concern | Booster category | Example products | What it targets |
|---|---|---|---|
| Dry & dehydrated | Hyaluronic-acid boosters | SKINVIVE (FDA-approved, 2023) | Hydration, glow, comfort |
| Dull, rough, reactive | PDRN / polynucleotides | Rejuran (Korea) | Texture, tone, skin quality |
| Early laxity, losing firmness | Collagen biostimulators | PLLA, PDLLA, Juvelook | Collagen production over months |
| Oily / acne-prone | Separate treatment plan | — | Boosters aren't acne treatments |
| Sensitive / allergy-prone | Safety screen first | Fish allergy relevant for PDRN | Provider leads with safety questions |
Dry & dehydrated
If skin feels tight, looks a little flat, and drinks up moisturizer without ever seeming satisfied, the conversation commonly turns to hyaluronic-acid boosters. Hyaluronic acid is a sugar the body already produces, and it holds a large amount of water relative to its molecular size. In a booster it is left loose rather than firmed into a gel, and is described as spreading through the skin and drawing in moisture rather than adding shape.
In 2023 the FDA approved SKINVIVE by JUVEDERM for improving skin smoothness of the cheeks. In AbbVie's approval data, satisfaction with skin hydration was reported at 72% at six months, compared with 24% at baseline.
Dull, rough, or reactive
If the concern is texture and tone more than dryness — skin that looks tired, a little rough, or easily irritated — repair-focused boosters are the category commonly discussed. Polynucleotide boosters are the salmon-derived group; the Korean brand Rejuran is one product in this category. A narrative review in the Journal of Cutaneous and Aesthetic Surgery describes them as acting on the skin's own machinery and dampening inflammatory signalling.
Because Rejuran is salmon-derived, it may not be suitable for those with a fish allergy — worth mentioning before a consultation, and something a provider will screen for.
Losing firmness, or mature skin
If the concern is early laxity, a softening jawline, or skin that has lost some bounce, the conversation commonly turns to collagen biostimulators — poly-lactic-acid products such as PLLA and PDLLA. These are not intended to add water or fill a line; the category is described as stimulating the body's own collagen production over time. A 2025 systematic review reported improvements in skin elasticity, wrinkle appearance and facial volume, with reported changes building over months rather than days.
Skin type is a starting point, not a verdict
"Dry" and "oily" are rough handles, and skin rarely reads as one clean category. The actual matching is done by concern — what actually bothers you — and by a provider assessing your skin in person. Two people who would both describe themselves as "combination, a bit dull" can walk out with different recommendations, and that is not inconsistency; it is the assessment doing its job.
You do not need to arrive knowing which booster you want. It is often more useful to arrive able to describe what you would change if you could, and let the person in front of you translate that into options. Bring the mirror thought, not the brand name.
Sources ▶ 1) AbbVie — "SKINVIVE™ by JUVÉDERM® Receives U.S. FDA Approval" (May 2023); 2) Journal of Cutaneous and Aesthetic Surgery — PDRN narrative review; 3) Aesthetic Plastic Surgery, 2025 — Collagen Biostimulators Systematic Review. Trial figures reflect pivotal-study data.
